2 hours Activist Starboard Value Takes $1 Billion Stake in Pfizer The Wall Street Journal
The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments has slowed.
The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments has slowed.